September 2019

Ebola breakthrough

Ebola could soon be “preventable and treatable”, after a trial of two drugs showed significantly improved survival rates.

Chlamydia vaccine on horizon

The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response.

Emergency and disaster situations

Warren Johns is one of the authors of the WHO book: Health laboratory facilities in emergency and disaster situations. He talks about his experiences, followed by a review of the book by Neil Bentley OBE from the National Infection Services.

Smart sensors for bandages

Scientists are developing smart sensors which can monitor the healing progress of a wound, eliminating the need to look underneath a bandage.

Sustainable pathology

With climate change and sustainability becoming a significant focal point for any sector, it’s hard to ignore healthcare’s need for transformation, argues Specialist Biomedical Scientist Carmen Holmberg.

Here to Help: Education and training standards

Now that September is here, Jocelyn Pryce, Deputy Head of Education at the IBMS, gives an update.

Dolly the manmade sheep

In an exclusive interview, Sir Ian Wilmut discusses genetic engineering, his recent Parkinson’s diagnosis and, of course, the most famous sheep in the world.

Obituary: former IBMS President Eric James Cloke

Eric James Cloke, known by all as “Jim”, was the President of the Institute from 1988 to 1991. 

September journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Promoting professionalism, reforming regulation: A review of the issues and the Government response to the consultation

A rethink on healthcare regulation, and the regulators themselves, has been long in the pipeline. After the Government consultation of early 2018, the Government’s response has now been published. IBMS Deputy Chief Executive Sarah May responds.

Laboratory errors in transfusion

Jenny Berryman and Paula Bolton-Maggs from the Serious Hazards of Transfusion (SHOT) scheme explain their latest annual report.

Top